While there has been significant global progress in curbing conventional tobacco products, newer tobacco and nicotine products such as e-cigarettes are evading regulation, according to the World Health Organization (WHO) 2021 report on the tobacco epidemic. Some 5.3 billion people are now covered by at least one of the six tobacco ‘MPower’ control measures recommended […] Continue reading ->
The long-delayed 2020 edition of the Tokyo summer Olympics opened Friday against the sober backdrop of soaring COVID infection rates, but with plenty of pomp and ceremony nonetheless –  including a massive fireworks display and an aerial show of drones resembling planet earth hovering above Olympic Stadium, while John Lennon’s “Imagine” echoed across the night […] Continue reading ->
The World Trade Organisation’s (WTO) Council for Trade-Related Aspects of Intellectual Property Rights (TRIPS) remains deadlocked on the “fundamental question” of whether a waiver on intellectual property rights of COVID-related products is the best way to address equitable vaccine access during the pandemic. This is according to a draft oral status report adopted at Tuesday’s […] Continue reading ->
People living with HIV face a significant risk of severe COVID-19 and should be prioritised in national vaccination programmes, according to research presented on Thursday ahead of  the International AIDS Society’s (IAS) HIV Science conference which starts on Saturday. The World Health Organization (WHO) research looked at the data of 15,500 HIV positive people from […] Continue reading ->
Pharmaceutical companies continue to develop COVID-19 vaccine boosters amid condemnation of people in wealthy countries getting additional shots when much of the world is unvaccinated. The US Health and Human Services Department reiterated on Monday that booster shots were not necessary for fully vaccinated Americans after meeting with Pfizer, which is conducting a booster trial. […] Continue reading ->
CoronaVac, the Chinese vaccine developed by Sinovac, offers 83.5% protection against symptomatic COVID-19, according to interim data from a Phase 3 trial in Turkey published in the Lancet on Friday.  Meanwhile, a large study of the efficacy of the vaccine on 10.2 million Chileans found that it was 65.9% effective in preventing infection, 87,5% effective […] Continue reading ->